Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

National Registry of Robotically Assisted Surgery

HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP

This public procurement record has 3 releases in its history.

Award

14 Sep 2026 at 15:21

UK6 - Contract Award Notice
TenderUpdate

27 Mar 2026 at 14:06

UK4 - Tender Notice
Tender

04 Mar 2026 at 10:44

UK4 - Tender Notice
Summary of the contracting process

Healthcare Quality Improvement Partnership Ltd commissioned a national registry for robotically assisted surgery in NHS-funded care in England. The service is a health-service and data programme covering prospective collection of surgical data, patient safety and outcome tracking, quality metrics aligned with NICE evaluations, comparison of providers and conventional techniques, and analysis of variation, inequity and poor outcomes. It is also intended to support clinical guidance, commissioning, regulation, research and innovation. The registry must engage clinicians, healthcare providers, patients, carers, commissioners and community organisations, and work with NICE, NHS England, the Medicines and Healthcare products Regulatory Agency and the National Equipment Tracking and Information System. The supplier must develop data platforms and tools, plan data linkage and interoperability, and establish a sustainable future funding model. Delivery is for England.

This procurement is complete and was awarded through an above-threshold open procedure. The contract was awarded to the University of Leeds on 7 September 2026. The core contract period is 1 November 2026 to 31 October 2029, with an option for up to 24 months’ renewal, potentially extending to 31 October 2031. The awarded value is £8,640,646.40 excluding VAT, or £10,800,808 including VAT, including potential extension and aspirational measures. The tender’s stated core budget was £1,083,600 excluding VAT, or £1,300,320 including VAT. Seven bids were received and one reached the final stage. Evaluation weighted quality at 95% and price at 5%, with quality covering governance, patient involvement, provider engagement, data acquisition, information governance, analysis, data use, delivery, risk and social value. The original enquiry deadline was 30 March 2026 and bid deadline 27 April 2026.

The award demonstrates demand for suppliers able to design and operate clinically led national health registries, rather than simply provide a software platform. A credible competitor would need strong expertise in prospective healthcare data collection, information governance, interoperability, data linkage, statistical analysis and production of timely, accessible outputs for different audiences. Experience working with NHS organisations, clinicians, commissioners, patients and public contributors would be important, alongside the ability to manage provider participation and minimise data-collection burden. The requirement also favours organisations able to align metrics with NICE guidance, support evidence generation and post-market or safety activity, and adapt the registry as robotic surgery develops. Suppliers should be able to establish accountable governance with public-sector partners, manage risks, support quality improvement and design a sustainable funding model. The opportunity was identified as suitable for SMEs and voluntary, community or social enterprises.

How relevant is this notice?

Notice Information

Notice Title

National Registry of Robotically Assisted Surgery

Notice Description

The contract will initially be delivered for NHS-funded care in England for a period of 3 years, at a maximum total budget of up to PS1,300,320 including VAT, PS1,083,600 excluding VAT. Bids exceeding this limit may be rejected. There is the potential to extend this contract for up to 24 months via either a funded extension or the method stated in section 4.2 of Annex A. All pricing submissions must be in regard to this 'core' value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of PS1,300,320 including VAT, PS1,083,600 excluding VAT. The maximum budget 'core' value of PS1,300,320 including VAT, PS1,083,600 excluding VAT excludes the potential two year extension and aspirational intent as described in section 14.4 of Annex A - Service Specification. Please note, there is no commitment by the Authority at this stage to include any aspirational intent measures. Taking the total of this aspirational intent into account, as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is PS10,800,808 GBP including VAT, PS8,640,646.40 excluding VAT. The registry should aim to address, where possible and as a priority, the recommendations and requirements of the NICE early evaluation assessment (EVA) and is expected to support the acquisition of relevant metrics. NICE EVA orthopaedics - https://www.nice.org.uk/guidance/htg743/resources/evidence-generation-plan-for-robotassisted-surgery-for-orthopaedic-procedures-15306435181/chapter/1-Purpose-of-this-document and NICE EVA soft tissue - https://www.nice.org.uk/guidance/htg742 The registry will continue to evolve in line with the uptake of robotic surgery working with Medicines and Healthcare products Regulatory Agency (MHRA), NHSE, National Equipment Tracking and Information System (NETIS) and NICE to ensure evidence generation, availability of data for analysis to highlight variations in care and poor outcomes including health inequities The aims of the national robotically assisted surgical registry are to: *Improve patient safety by tracking short- and long-term results of robotically assisted surgery *Capture key quality metrics aligned with the requirements of the NICE EVA recommendations (see section 9.3) *Support the standardisation of practice *Identify variation in surgical outcomes across hospitals *Provide outcome evidence to inform clinical guidelines, commissioning, and regulatory decisions *Facilitate research and innovation conducted by others in robotic surgical technologies and techniques *Understand the current provision and the equity of access to help inform future strategic decisions. *Make available, near real time data for authorities to evaluate the effectiveness of robotically assisted surgery compared with conventional techniques *Maintain close alignment with relevant NICE national guidance and quality standards throughout the establishment of the registry (see section 9.1 and appendix 1) *Provide timely and high-quality data analysis that compares providers of healthcare *Be clinically led *Link data where feasible and of value at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract *Use robust methodological and statistical techniques (see section 6.2.2) *Provide outputs tailored to a variety of different audiences Provide results in a timely, accessible and meaningful manner minimising the reporting delay and providing continual access to each stakeholder for their own data *Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services The project requirements are*: *A registry that captures prospective key data about robotically assisted surgery. This registry should be delivered by 2029 therefore, before the end of year three of the contract *The provision of information to address, where possible, the evidence gaps highlighted by the NICE medical technologies advisory committee concerning promising health technologies that have the potential to address national unmet need (see: Committee discussion) *To, during the first three years, design a self-sustaining style funding model. The funder and commissioner should be involved in all discussions with final sign-off approval. It is anticipated that at the end of the 3-year contract term the funding should switch from a publicly funded to a self-sustaining funding model. Given the pump priming publicly funded start up to this project, the expectation is that the current funders will be involved at all stages of the self-sustaining future model and be integrally involved as a primary stakeholder in the governance and oversight *With the set up and implementation of a self-sustaining financial model, the registry should consider a mechanism to enable the flow of data to robotic manufacturers named in the NICE EVA (or other safety programmes) and who contribute to the funding of the registry when the self-sustaining model is developed. Information for manufacturers may potentially include data for product and system improvement, safety and post-market surveillance, benchmarking and performance feedback, value demonstration, collaborative research and development. The supplier should avoid providing information to manufacturers that supports commercial messaging or market advantage and be confined to information relating to service user outcomes *That the registry's design and governance arrangements consider the remit and existing data holdings of other similar registries and data collections, ensuring interoperability where appropriate and avoiding duplication of data collection, analytical outputs, or reporting functions *At the conclusion of the three-year contract term, the strategic intention is for the registry to mature into a continuous, prospective data collection underpinned by a sustainable, self- funding model. This transition must not dilute or displace the required system-level oversight. HQIP and NHSE will therefore remain central and non-negotiable partners within the governance framework for the registry throughout the contract and into any subsequent phase *The supplier will be required, to commit to this governance structure, including the roles of HQIP and NHSE, and to demonstrate how their proposed operating model will support effective accountability, assurance and long-term sustainability *The development of this registry including data platforms and tools within this contract are initially a proof of concept and future delivery arrangements are currently unknown. If a self-funding model is agreed and developed as defined in this section (3.2), it will form part of the contractual deliverable requirements, specifically adhering to clause 20, intellectual property, of the terms and conditions. Migration to a definitive platform under future commissioning arrangements may be necessary and the future portability of a technical solution must be considered and be freely available to transition between any outgoing and incoming providers, along with all other foreground IPR rights contained within clause 20 of the terms and conditions *There may be a clinical need to evolve and expand the metrics to capture additional metrics outside of the NICE EVA requirements. The supplier will need to closely collaborate with NICE to consider changes to metrics and mutually agreeable metric modifications. *The registry will continue to evolve in line with the uptake of robotic surgery working with MHRA, NHSE, NETIS and NICE to ensure evidence generation, availability of data for analysis to highlight variations in care and poor outcomes including health inequities *Please refer to section 13.2 for further potential additional requirements for this contract.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0661d2
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/086981-2026
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME, VCSE
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
£8,640,646 £1M-£10M
Lots Value
£8,640,646 £1M-£10M
Awards Value
£8,640,646 £1M-£10M
Contracts Value
Not specified

Notice Dates

Publication Date
14 Sep 2026Yesterday
Submission Deadline
27 Apr 2026Expired
Future Notice Date
Not specified
Award Date
7 Sep 20261 weeks ago
Contract Period
1 Nov 2026 - 31 Oct 2029 3-4 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
HEALTHCARE QUALITY IMPROVEMENT PARTNERSHIP
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
EC2V 6DL
Postcode Area
Central London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI35 Westminster and City of London
Delivery Location
Not specified
Local Authority
City of London
Electoral Ward
Cheap
Westminster Constituency
Cities of London and Westminster

Supplier Information

Number of Suppliers
1
Supplier Name

University of Leeds

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...